Stay updated on Emricasan for Decompensated NASH Cirrhosis Clinical Trial

Sign up to get notified when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or revision in the study details related to the safety and efficacy evaluation of emricasan in subjects with decompensated NASH cirrhosis.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:54.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying that researchers are looking for individuals who meet certain health conditions and treatment histories. The new criteria outline key inclusion and exclusion factors, such as age, health status, and specific medical conditions.
    Difference
    19%
    Check dated 2024-05-22T21:14:34.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:25:04.000Z thumbnail image

Stay in the know with updates to Emricasan for Decompensated NASH Cirrhosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.